The combination of fludarabine and cyclophosphamide has a beneficial effect on the incidence of hemolytic anemia in chronic lymphocytic leukemia. Results from the UK LRF CLL4 trial

The combination of fludarabine and cyclophosphamide has a beneficial effect on the incidence of hemolytic anemia in chronic lymphocytic leukemia. Results from the UK LRF CLL4 trial

Bibliographic Details
Main Authors: Dearden, C, Wade, R, Else, M, Richards, S, Milligan, D, Hamblin, T, Catovsky, D
Format: Conference item
Published: 2007

Similar Items